Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma: A case report

doi:10.12998/wjcc.v11.i2.441

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2374)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

127

WORD

HTML

1351

Figures (1-4)

364

Sum=1888

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

144

Download

342

Sum=486

Jan 16, 2023 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jan 16, 2023; 11(2): 441-448
Published online Jan 16, 2023. doi: 10.12998/wjcc.v11.i2.441

Full Size Figure Download Figure

Figure 4 Histopathological section of computed tomography -guided percutaneous lung biopsy specimen showing lung invasive mucinous adenocarcinoma (H&E stain, 200×).

Citation: Ou GC, Luo W, Zhang WS, Wang SH, Zhao J, Zhao HM, Qiu R. Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma: A case report. World J Clin Cases 2023; 11(2): 441-448
URL: https://www.wjgnet.com/2307-8960/full/v11/i2/441.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i2.441